Abstract
The recent Coronavirus (COVID-19) has been spreading through all the world fastly. In this work we focus on the evolution of the COVID-19 in one of the most populous Brazilian states, namely the Rio de Janeiro state. The first case was reported in March 5, 2020, thus we have a considerable amount of available data to make a good analysis. First we study the early evolution of the disease, considering a Susceptible-Infectious-Quarantined-Recovered (SIQR) model. This initial phase shows the usual exponential growth of the number of confirmed cases. In this case, we estimate the parameters of the model based on the data, as well as the epidemic doubling time. After, we analyze all the available data, from March 5, 2020 through April 26, 2020. In this case, we observe a distinct behavior: a sub-exponential growth. In order to capture this change in the behavior of the evolution of the confirmed cases, we consider the implementation of isolation policies. The modified model agrees well with data. Finally, we consider the relaxation of such policies, and discuss about the ideal period of time to release people to return to their activities.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The author acknowledges financial support from the Brazilian scientific funding agencies Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) and Fundação de Amparo à Pesquisa do Estado do Rio de Janeiro (FAPERJ).
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data are available in the link provided in the specific location, as well as in the references of the manuscript.
